.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Citi
Accenture
Dow
Teva
Baxter
Chinese Patent Office
McKinsey
Fuji
Express Scripts

Generated: June 27, 2017

DrugPatentWatch Database Preview

DILTIAZEM HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Diltiazem Hydrochloride, and what generic Diltiazem Hydrochloride alternatives are available?

Diltiazem Hydrochloride is a drug marketed by Hospira, Mylan, Valeant Pharms North, Athenex Inc, Sun Pharma Global, Sandoz, Sun Pharm Inds Ltd, West-ward Pharms Int, Biovail, Apotex, Intl Medication, Hikma Farmaceutica, Apothecon, Actavis Labs Fl Inc, Actavis Elizabeth, Nesher Pharms, Teva Pharms, Ivax Sub Teva Pharms, Mylan Labs Ltd, Teva, Par Pharm, Akorn Inc, Chartwell Molecules, and Teva Pharms Usa. and is included in thirty-four NDAs.

The generic ingredient in DILTIAZEM HYDROCHLORIDE is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

Summary for Tradename: DILTIAZEM HYDROCHLORIDE

Patents:0
Applicants:24
NDAs:34
Suppliers / Packagers: see list40
Bulk Api Vendors: see list50
Clinical Trials: see list2,307
Patent Applications: see list2,050
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DILTIAZEM HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DILTIAZEM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074168-004Mar 3, 1995DISCNNoNo► Subscribe► Subscribe
Chartwell Molecules
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074093-003Nov 5, 1992DISCNNoNo► Subscribe► Subscribe
Hospira
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
INJECTABLE;INJECTION074941-001Apr 15, 1998APRXNoNo► Subscribe► Subscribe
Mylan
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL072838-003Nov 5, 1992ABRXNoNo► Subscribe► Subscribe
Teva
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074185-004May 31, 1995ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DILTIAZEM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-002Jan 28, 20005,529,791► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-003Jan 28, 20005,529,791► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-001Jan 28, 20005,288,505► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-002Jan 28, 20005,288,505► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-004Jan 28, 20005,288,505► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
McKesson
Cantor Fitzgerald
Fish and Richardson
US Department of Justice
Fuji
Medtronic
Teva
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot